BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 29165383)

  • 21. Vascular aspects of cognitive impairment and dementia.
    Wiesmann M; Kiliaan AJ; Claassen JA
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1696-706. PubMed ID: 24022624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between NADPH oxidase-mediated oxidative stress and dysfunction of endothelial progenitor cell in hyperlipidemic patients.
    Li TB; Zhang YZ; Liu WQ; Zhang JJ; Peng J; Luo XJ; Ma QL
    Korean J Intern Med; 2018 Mar; 33(2):313-322. PubMed ID: 28899085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taurine Attenuates Calpain-2 Induction and a Series of Cell Damage via Suppression of NOX-Derived ROS in ARPE-19 Cells.
    Zhang Y; Ren S; Gu Y; Wang J; Liu Z; Zhang Z
    Oxid Med Cell Longev; 2018; 2018():4596746. PubMed ID: 30151070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
    Sahoo S; Meijles DN; Pagano PJ
    Clin Sci (Lond); 2016 Mar; 130(5):317-35. PubMed ID: 26814203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Enigmatic Vascular NOX: From Artifact to Double Agent of Change: Arthur C. Corcoran Memorial Lecture - 2019.
    Pagano PJ; Cifuentes-Pagano E
    Hypertension; 2021 Feb; 77(2):275-283. PubMed ID: 33390049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications.
    Urner S; Ho F; Jha JC; Ziegler D; Jandeleit-Dahm K
    Antioxid Redox Signal; 2020 Aug; 33(6):415-434. PubMed ID: 32008354
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular dementia: distinguishing characteristics, treatment, and prevention.
    Román GC
    J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S296-304. PubMed ID: 12801386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and mechanisms of ROS generation by NADPH oxidases.
    Magnani F; Mattevi A
    Curr Opin Struct Biol; 2019 Dec; 59():91-97. PubMed ID: 31051297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia?
    Zekry D; Epperson TK; Krause KH
    IUBMB Life; 2003 Jun; 55(6):307-13. PubMed ID: 12938732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvascular NADPH oxidase in health and disease.
    Li Y; Pagano PJ
    Free Radic Biol Med; 2017 Aug; 109():33-47. PubMed ID: 28274817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of apocynin on vascular disease in hypertension.
    Virdis A; Gesi M; Taddei S
    Vascul Pharmacol; 2016 Dec; 87():1-5. PubMed ID: 27569106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nox enzymes and oxidative stress in atherosclerosis.
    Manea A; Simionescu M
    Front Biosci (Schol Ed); 2012 Jan; 4(2):651-70. PubMed ID: 22202083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress.
    Liu H; Zhang J
    Int J Neurosci; 2012 Sep; 122(9):494-9. PubMed ID: 22519891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NADPH Oxidases and Measurement of Reactive Oxygen Species.
    Amanso A; Lyle AN; Griendling KK
    Methods Mol Biol; 2017; 1527():219-232. PubMed ID: 28116720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox-Redux and NADPH Oxidase (NOX): Even More Complicated than We Thought it Might Be.
    Meyskens FL; Liu-Smith F
    J Invest Dermatol; 2017 Jun; 137(6):1208-1210. PubMed ID: 28532757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
    Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of nicotinamide-adenine dinucleotide phosphate oxidase NOX family in acute lung injury].
    Li D; Cong Z; Lyu X; Wu C; Tao Y; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):244-247. PubMed ID: 30827320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dementia, stroke, and vascular risk factors; a review.
    Sahathevan R; Brodtmann A; Donnan GA
    Int J Stroke; 2012 Jan; 7(1):61-73. PubMed ID: 22188853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NADPH oxidases and cardiac remodelling.
    Nabeebaccus A; Zhang M; Shah AM
    Heart Fail Rev; 2011 Jan; 16(1):5-12. PubMed ID: 20658317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.